For example, miR-193a-3p was shown to promote in vivo tumorigenesis of metastatic medullary thyroid carcinoma[28], and to enhance both tumor growth in nude mice and chemoresistance of HCC by targeting of the SRSF2 gene[29]. This evidence concerns the gene SRSF2 and hepatocellular carcinoma.